NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Active, not recruiting · NCT06459869 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer | Locally Advanced Rectal Cancer (LARC) | Active, not recruiting | Phase 1 | 2026-09-16 | NCT06459869 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akamis Bio | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AdventHealth Orlando | Orlando | United States | 23 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| The Royal Marsden NHS Foundation Trust | Sutton | United Kingdom | 3 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| University College London NHS FT | London | United Kingdom | 1 |
| University of Southern California | Los Angeles | United States | 110 |
| Washington University School of Medicine | St Louis | United States | 895 |